Status:
RECRUITING
PENG vs Intra-articular Injection for Hip Arthroscopy
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Opioid Use
Acute Pain
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Hip arthroscopy is a popular surgical method that is increasingly being used for both intraarticular and extraarticular hip surgeries. Postoperative acute pain is difficult to control in hip surgeries...
Eligibility Criteria
Inclusion
- American Association of Anesthesiologists (ASA) physical status I - III
- BMI 20 to 35 kg / m2
- Patients scheduled for elective hip arthroscopy
- Able to provide informed consent.
Exclusion
- Patients who refuse to participate in the study,
- Coagulopathy,
- Sepsis,
- Hepatic or renal insufficiency,
- Pregnancy
- Allergy to local anesthetic drugs,
- Chronic pain condition requiring opioid intake at home,
- BMI above 40.
- History of psychiatric diseases needing treatment.
- Failure of nerve block
- Substance abuse history
- Hip revision surgery
- Underlying neurologic disorder affecting pain perception.
- Angina, heart attack, heart failure
- Kidney or hepatic insufficiency
- Stroke
- Gastrintestinal bleeding history
Key Trial Info
Start Date :
January 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04698746
Start Date
January 20 2021
End Date
April 1 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakıf University
Istanbul, Turkey (Türkiye), 34093